TENX

1.25010.07%
SR

Stuart Rich

Chief Medical Officer & Director

Dr. Stuart Rich, M.D., serves as Chief Medical Officer at Tenax Therapeutics, Inc. since January 15, 2021 and serves as its Director since February 2021. He served as the Chairman of Scientific Advisory Board at Tenax Therapeutics, Inc. He joined the Company from PHPrecisionMed Inc. (PHPM), where he was a co-founder and held the positions of Chief Executive Officer and Director from October 2018 until January 2021. Beginning July 2015, Dr. Rich has served as Professor of Medicine (and since 2021, Professor Emeritus) at Northwestern University Feinberg School of Medicine. Dr. Rich served as the Chief Medical Officer (part-time) of United Therapeutics since October 2003 until December 2004. Dr. Rich has a career interest in understanding the causes and treatments of pulmonary hypertension. He was principal investigator for the National Institutes of Health (NIH) Registry on Primary Pulmonary Hypertension, the first of its kind and has been the leader of the largest clinical centers in the USA for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. Dr. Rich was Co-Founder of the Pulmonary Vascular Research Institute and served as member of the Board of Trustees since 2006 until 2023. Since July 2015, has also served as a Director of the Pulmonary Vascular Disease Program at the Bluhm Cardiovascular Institute. Since January 2011, he has served as a member of the Board of Directors of the Cardiovascular Medical and Research Foundation. This knowledge has led to the discovery of more effective treatments for pulmonary hypertension, including the use of medicines like anticoagulants, calcium channel blockers and prostacyclins. Dr. Rich was instrumental in the current classification system routinely used by physicians in characterizing the types of pulmonary hypertension. Prior to Northwestern University, Dr. Rich was the Professor of Medicine and Chief of the Section of Cardiology at the University of Illinois College of Medicine in Chicago since July 1980 until July 1996, was Professor of Medicine at the Rush Heart Institute of the Rush University School of Medicine from July 1996 until September 2004, and was Professor of Medicine at the Section of Cardiology of the University of Chicago Pritzker School of Medicine from September 2004 until July 2015. During his distinguished career, Dr. Rich has authored and published hundreds of articles and book chapters on pulmonary hypertension. He has received numerous awards recognizing his achievements including, the Heart for Hope Legacy Award from the Pulmonary Hypertension Association and the Lifetime Achievement Award from the Pulmonary Vascular Research Institute. Dr. Rich received his B.S. in Biology at the University of Illinois and his M.D. at Loyola University Stritch School of Medicine, and he completed his residency in medicine at the Washington University of St. Louis and his fellowship in cardiology at the University of Chicago.

Positions